Efficacy and Safety of IQP-VV-102 in Weight Management

• Register: ClinicalTrials.gov
• Last refreshed on: 19 October 2017
• Main ID: NCT01681069
• Date of registration: 04/09/2012
• Prospective Registration: Yes
• Primary sponsor: InQpharm Group
• Public title: Efficacy and Safety of IQP-VV-102 in Weight Management
• Scientific title: Double-blind, Randomized, Placebo-controlled, Bicentric Clinical Investigation to Evaluate the Safety and Efficacy of IQP-VV-102 in Reducing Body Weight in Overweight and Obese Subjects
• Date of first enrolment: October 2012
• Target sample size: 120
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT01681069
• Study type: Interventional
• Phase: Phase 3

Countries of recruitment

Germany

Contacts

• Name: Barbara Grube, MD
• Affiliation: Practice for General Medicine

Key inclusion & exclusion criteria

Inclusion Criteria:

- Age 18 to 60 years

- 25 kg/m2 = BMI = 35 kg/m2

- Written informed consent

Exclusion Criteria:

- Known sensitivity to sources of the active ingredients and excipients

- Pregnancy or nursing

- Inability to comply with study requirements, e.g. due to language difficulties

- Participation in another study during the last 30 days of the screening visit



Age minimum: 18 Years
Age maximum: 60 Years
Gender: All

Health Condition(s) or Problem(s) studied

Overweight

Obesity

Intervention(s)

Dietary Supplement: IQP-VV-102

Other: Placebo

Primary Outcome(s)

Change in Body Weight at End of Study Compared to Baseline [Time Frame: 12 weeks]

Secondary Outcome(s)

Change in Waist Circumference (in cm) at End of Study From Baseline [Time Frame: 12 weeks]

Change in Mean Body Fat at End of Study From Baseline [Time Frame: 12 weeks]

Secondary ID(s)

INQ/009712

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Results

• Results available: Yes
• Date Posted: 06/11/2015
• URL: https://clinicaltrials.gov/ct2/show/results/NCT01681069